| ORIGINAL ARTICLE |
|
| Year : 2020 | Volume
: 4
| Issue : 1 | Page : 1-3 |
|
|
Research on the role of toll-like receptor 2 and toll-like receptor 4 and its signal pathway in the pathogenesis of primary gout arthritis
RJ Cui1, M Li2, G Tuerxun2, Y Li3, SS Xie4
1 Department of Rheumatology and Immunology, College of Educational Science, Xinjiang Normal University, Urumqi, China
2 Department of Endocrinology, College of Educational Science, Xinjiang Normal University, Urumqi, China
3 Department of Emergency, Sixth Affiliated Hospital of Xinjiang Medical University, Urumqi, China
4 Department of Psychological, College of Educational Science, Xinjiang Normal University, Urumqi, China
Correspondence Address:
Dr. R J Cui
Department of Rheumatology and Immunology, Sixth Affiliated Hospital of Xinjiang Medical University, Urumqi
China
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/MTSP.MTSP_5_19
|
|
|
Objectives: The study objective was to research the role of toll-like receptor (TLR) 2 and TLR 4 and its signal pathway in the pathogenesis of primary gout arthritis. Methods: Seventy-two patients with primary gout arthritis were selected as the experimental group and 72 healthy controls were selected as the control group. The real-time fluorescence quantitative polymerase chain reaction method was used for testing. Blood uric acid (UA) level, interleukin (IL) IL-1β level, and TLR4 and TLR2 were observed in the two groups. Results: Compared with the control group, the levels of UA, IL-1β, and TLR4 in the observation group were significantly higher than those in the control group, and there was a statistically significant difference between the two groups (P < 0.05). There was no positive correlation between plasma UA level, IL-1β level, and TLR2 (P > 0.05). There was no correlation between TLR2 and serum UA level and IL-1β level in the control group (P > 0.05). Conclusions: TLR4 and IL-1β signaling acceleration is closely related to gouty arthritis. When the TLR4 signal pathway is activated, the UA salt crystal changes in the patient's body.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
